BioNTech SE Deferred Tax Assets
BioNTech SE (BNTX) had Deferred Tax Assets of EUR 13.50 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxAssets · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets 13.50M EUR.
- 2024-12-31: Deferred Tax Assets 81.70M EUR.
- 2023-12-31: Deferred Tax Assets 81.30M EUR.
- 2022-12-31: Deferred Tax Assets 229.60M EUR.
| Period end | Deferred Tax Assets | Deferred Tax Assets as first filed |
|---|---|---|
| 2025-12-31 | 13.50M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 81.70M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 81.30M EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 229.60M EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 0.00 EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 161.20M EUR 20-F/A · filed 2022-10-26 | 161.23M EUR 20-F · filed 2021-03-30 |